Search

Your search keyword '"Hatano, Koji"' showing total 779 results

Search Constraints

Start Over You searched for: Author "Hatano, Koji" Remove constraint Author: "Hatano, Koji"
779 results on '"Hatano, Koji"'

Search Results

1. Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan

4. GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment

13. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory

15. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients

16. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer

17. Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study

25. MP05-07 GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER FOR CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASIS VIA PROMOTING THE VICIOUS CYCLE

26. PD35-03 GENOME-WIDE CRISPR SCREENS IDENTIFIED THAT DCLRE1C REGULATES THE RADIOSENSITIVITY OF PROSTATE CANCER

27. MP41-05 LIQUID-BIOPSY BASED NOVEL mRNA GENOMIC TEST FOR EARLY DETECTION, PROGNOSIS AND MONITORING OF PROSTATE CANCER: A MULTICENTER STUDY

28. MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME

29. The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study

30. Cutibacterium acnes‐derived extracellular vesicles promote tumor growth in renal cell carcinoma.

31. Cumulative Incidence and Risk Factors for Anti-Resorptive Agent-Related Osteonecrosis of the Jaw during Long-Term Prostate Cancer Management

33. GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER BY ENHANCING THE VICIOUS CYCLE OF BONE METASTASIS

34. ALANINE RESTRICTION CAN INHIBIT CARCINOGENESIS IN A NOVEL MOUSE MODEL OF UPPER TRACT UROTHELIAL CARCINOMA

37. Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study

40. FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab

41. Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma

42. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab

44. MO25-4 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma

45. Long-term safety and efficacy of enzalutamide for men with castration-resistant prostate cancer: a multicenter, prospective DELC study

49. Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma

Catalog

Books, media, physical & digital resources